HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of drug-resistant human neuroblastoma cells with cyclodextrin inclusion complexes of aphidicolin.

Abstract
Treatment failure in most neuroblastoma (NB) patients is related to primary and/or acquired resistance to conventional chemotherapeutic agents. Aphidicolin (APH), a tetracyclic diterpene, exhibits specific cytotoxic action against NB cells. The purpose of this study was to compare antitumoral efficacy of APH in parental NB cell lines and cell subclones that exhibit drug resistance to vincristine (VCR), doxorubicin (DOX) and cisplatin. Due to poor solubility of APH in water, gamma-cyclodextrin (gamma-CD) inclusion complexes of APH were used for systemic treatment of xenotransplanted parental and VCR-resistant UKF-NB-3 tumours. APH and its gamma-CD inclusion complexes inhibited growth of parental and drug-resistant NB cells at equimolar doses in vitro. Growth of VCR-sensitive and -resistant NB tumors was inhibited at equal doses in a dose-dependent fashion in vivo. These results indicate that the specific cytotoxic activity of APH against NB cells in vitro and in vivo is independent of cellular mechanisms facilitating drug resistance to conventional chemotherapeutic drugs. Hence, taking into account our previous findings that APH acts synergistically with VCR and DOX, APH might be an additive tool for the therapy of NB and is suitable for evaluation in clinical studies of NB treatment protocols.
AuthorsM Michaelis, J Cinatl, J U Vogel, P Pouckova, P H Driever, J Cinatl
JournalAnti-cancer drugs (Anticancer Drugs) Vol. 12 Issue 5 Pg. 467-73 (Jun 2001) ISSN: 0959-4973 [Print] England
PMID11395575 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Cyclodextrins
  • Drug Carriers
  • Enzyme Inhibitors
  • Aphidicolin
Topics
  • Animals
  • Antineoplastic Agents (therapeutic use)
  • Aphidicolin (analogs & derivatives, therapeutic use)
  • Body Weight (drug effects)
  • Cell Survival (drug effects)
  • Cyclodextrins (pharmacology)
  • Drug Carriers
  • Drug Resistance, Neoplasm
  • Enzyme Inhibitors (therapeutic use)
  • Female
  • Humans
  • Mice
  • Mice, Nude
  • Neuroblastoma (drug therapy, pathology)
  • Tumor Cells, Cultured (drug effects, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: